<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33420">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01850719</url>
  </required_header>
  <id_info>
    <org_study_id>NL4418.100.13</org_study_id>
    <nct_id>NCT01850719</nct_id>
  </id_info>
  <brief_title>Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients</brief_title>
  <acronym>ESCAPE</acronym>
  <official_title>Cost-effectiveness of Early Surgery Versus Conservative Treatment With Optional Delayed Meniscectomy in Older Patients. A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Onze Lieve Vrouwe Gasthuis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZonMw: The Netherlands Organisation for Health Research and Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zilverenkruis Achmea - Stichting Achmea Gezondheidszorg (SAG)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Onze Lieve Vrouwe Gasthuis</source>
  <oversight_info>
    <authority>Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effectiveness of both arthroscopic knee
      surgery and physical therapy in the treatment of non-obstructive meniscal injuries in older
      patients.

      The investigators assume equal improvement of physical function in both groups and reduced
      costs with conservative treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale: Arthroscopic Partial Meniscectomy (APM) is the most performed orthopaedic
      procedure and is current standard treatment for patients with meniscal tears. Since
      superiority of APM over conservative treatment has not well been described and studies with
      direct comparison between APM and conservative treatment are sparse, therefore there is risk
      of large healthcare inefficiency.

      Study design: Non-inferiority multicenter randomized controlled trial with an economic
      evaluation alongside. The study will be conducted by the Orthopaedic Research Consortium
      Mid-West Netherlands and performed in 6 clinics, including 2 academic medical centers.

      402 patients between 45 and 70 years with Magnetic Resonance Imaging (MRI)-confirmed
      symptomatic, non-obstructive meniscal tears will be included. Patients will be assigned to
      either APM (n=201) or Physical Therapy (PT; n=201), with optional delayed APM (cross-over)
      when conservative treatment has failed. Block randomization will be done stratified for age
      and site. Data will be analysed on both intention to treat and per protocol basis.

      Measurement points:

        -  Patients will be asked to complete questionnaires at baseline and 3, 6, 9, 12, 18 and
           24 months.

        -  At both 3 and 24 months they will visit the outpatient department for physical
           examination.

        -  At 24 months an X-ray will be obtained.

      Sample size calculation: 402 patients, based on a power of 90%, an alpha of 0.05, a standard
      deviation of 20 points and a non-inferiority threshold of 8 points on the IKDC 'Subjective
      Knee Form'. Loss to follow up and cross-over have been taken into account in this
      calculation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>International Knee Documentation Committee 'Subjective Knee Form'</measure>
    <time_frame>3, 6, 12 and 24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Primary outcome will be change in physical function from baseline to 2 years measured by the International Knee Documentation Committee (IKDC) 'Subjective Knee Form', which has been validated for meniscal injuries.
In addition, the investigators will perform an economic analysis alongside the Randomized Controlled Trial (RCT) from a societal perspective and a budget impact analysis from societal, government and insurer perspective.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>RAND-36 Physical Functional Status Scale</measure>
    <time_frame>3, 6, 12 and 24 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D-5L Quality of life measure</measure>
    <time_frame>3, 6, 9, 12, 18 and 24 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tegner Activity Scale</measure>
    <time_frame>3, 6, 12 and 24 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Care Utilization and productivity losses</measure>
    <time_frame>3, 6, 9, 12, 18 and 24 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Specific Complaints questionnaire</measure>
    <time_frame>3, 6 ,12 and 24 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Examination</measure>
    <time_frame>3 and 24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Performance on meniscus specific physical tests, joint line tenderness and the existence of joint effusion in the knee.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS pain score</measure>
    <time_frame>3, 6, 12 and 24 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">402</enrollment>
  <condition>Meniscal Tear</condition>
  <arm_group>
    <arm_group_label>Arthroscopic Partial Meniscectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Physical Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Arthroscopic Partial Meniscectomy</intervention_name>
    <description>Arthroscopic partial APM is performed within 4 weeks in day-care. No standard physical therapy is prescribed after surgery, as advised by the Dutch Orthopaedic Association Guidelines.</description>
    <arm_group_label>Arthroscopic Partial Meniscectomy</arm_group_label>
    <other_name>APM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical Therapy</intervention_name>
    <description>Conservative treatment consist of 16 sessions PT and a home exercise program. These programs are developed for our population, 45-70 years, with a focus on closed-chain strength exercises and cardiovascular exercises.
In case conservative treatment has failed, patients can cross-over and delayed APM is then performed. This can be done, from completion of the PT program, during the entire study.</description>
    <arm_group_label>Physical Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients between 45 and 70 years of age at presentation.

          -  A meniscal tear visualized on MRI. The meniscal tear can either be isolated or
             combined with a partial asymptomatic Anterior Cruciate Ligament (ACL) injury or an
             asymptomatic degenerative ACL shown on MRI with no abnormal clinical findings (a
             negative Lachman test and Pivot Shift).

          -  Mental Competence.

          -  Willingness to comply with follow up schedule.

          -  Written informed consent.

        Exclusion Criteria:

          -  Knee locking or trauma leading to acute surgery.

          -  One of the following associated injuries on the index knee:

               1. A symptomatic partial ACL rupture or any total ACL rupture determined by
                  clinical examination (positive Lachman test and/or positive Pivot Shift) and
                  shown on MRI;

               2. A complete Posterior Cruciate Ligament (PCL) injury;

               3. Cartilage change down to bone; grade 4 of the Kellgren Lawrence Grading Scale
                  for Osteoarthritis visualized on X-ray;

               4. An injury to the lateral/posterolateral ligament complex with significantly
                  increased laxity.

          -  A history of knee surgery other than diagnostic arthroscopy on the index knee.

          -  Tumors on MRI suspected for a malignancy.

          -  Obese patients with Body Mass Index (BMI) &gt; 35.

          -  ASA 4-5 patients which can severely interfere with rehabilitation.

          -  General disease that effects physical function or systemic medication/abuse of
             steroids (e.g., rheumatoid arthritis, psoriatic arthritis, systemic lupus
             erythematosus, gout, pseudogout)

          -  Any other medical condition or treatment interfering with the completion or
             assessment of the trial, e.g. contraindications to MRI or surgery.

          -  Drugs or alcohol abuse.

          -  Patients unable to speak or read Dutch.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rudolf W Poolman, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. Orthopaedic Surgery Onze Lieve Vrouwe Gasthuis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arthur de Gast, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. Orthopaedic Surgery Diakonessenhuis, Utrecht</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Douwe J Hemrika, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Dean Board of Directors Onze Lieve Vrouwe Gasthuis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eduard LAR Mutsaerts, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Orthopaedic Surgery Onze Lieve Vrouwe Gasthuis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Victor A van de Graaf, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Dept. of Orthopaedic Surgery Onze Lieve Vrouwe Gasthuis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Casper P Schönhuth, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Orthopaedic Surgery VU University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gino MMJ Kerkhoffs, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Orthopaedic Surgery Academic Medical Center University of Amsterdam</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maurits R Veen, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Orthopaedic Surgery St. Antonius Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julius Wolkenfelt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Orthopaedic Surgery St. Lucas Andreas Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maurits W van Tulder, professor</last_name>
    <role>Study Director</role>
    <affiliation>Professor of Health Technology Assessment Dept. Health Sciences VU University Amsterdam</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vanessa AB Scholtes, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Research coordinator Dept. of Orthopaedic Surgery Onze Lieve Vrouwe Gasthuis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nienke Wolterbeek, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Research coordinator Dept. of Orthopaedic Surgery St. Antonius Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Victor A van de Graaf, MD</last_name>
    <phone>0031 0205999111</phone>
    <phone_ext>1067</phone_ext>
    <email>v.a.vandegraaf@olvg.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rudolf W Poolman, MD PhD</last_name>
    <phone>0031 0205999111</phone>
    <phone_ext>1065</phone_ext>
    <email>r.w.poolman@olvg.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medisch Centrum Alkmaar</name>
      <address>
        <city>Alkmaar</city>
        <state>Noord Holland</state>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dirk-Jan Hofstee, MD</last_name>
      <phone>+31-(0)72 5482500</phone>
      <email>D.J.Hofstee@mca.nl</email>
    </contact>
    <investigator>
      <last_name>Dirk Jan Hofstee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Onze Lieve Vrouwe Gasthuis</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord Holland</state>
        <zip>1090 HM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victor A van de Graaf</last_name>
      <phone>0031 (0)205999111</phone>
      <phone_ext>1067</phone_ext>
    </contact>
    <contact_backup>
      <last_name>Rudolf W Poolman</last_name>
      <phone>0031 (0)205999111</phone>
      <phone_ext>1065</phone_ext>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St Lucas Andreas Hospital</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord Holland</state>
        <zip>1006 AE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J Wolkenfelt, MD</last_name>
      <phone>0031 (0)205108911</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center University of Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord Holland</state>
        <zip>1100 DD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>G MMJ Kerkhoffs, MD PhD</last_name>
      <phone>0031 (0)205669111</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medisch Centrum Jan van Goyen</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord Holland</state>
        <zip>1075 HN</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>E LAR Mutsaerts, MD PhD</last_name>
      <phone>0031 (0)203055817</phone>
      <email>e.l.a.r.mutsaerts@olvg.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>VU University Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord Holland</state>
        <zip>1007 MB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>C P Schönhuth, MD</last_name>
      <phone>0031 (0)204445402</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Diakonessenhuis</name>
      <address>
        <city>Utrecht</city>
        <zip>3508 TG</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>A de Gast, MD PhD</last_name>
      <phone>0031 (0)882506912</phone>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 9, 2014</lastchanged_date>
  <firstreceived_date>May 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Onze Lieve Vrouwe Gasthuis</investigator_affiliation>
    <investigator_full_name>Victor van de Graaf</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Tibial meniscus</keyword>
  <keyword>Arthroscopy</keyword>
  <keyword>Meniscectomy</keyword>
  <keyword>Conservative treatment</keyword>
  <keyword>Physical therapy</keyword>
  <keyword>Osteoarthritis knee joint</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
